In this episode, we speak with Dr. Noa Avni, Director of Research and Development at Nuroxone Biologic, about her groundbreaking work in regenerative medicine. Dr. Avni shares insights into how her team is using exosome-based therapies to develop innovative treatments for spinal cord injuries, a condition with limited options today. She also delves into the unique challenges of transitioning from diagnostics to drug development, the crucial role intellectual property plays in medical innovation, and the importance of building a strong, motivated team in a startup environment. Join us for an inspiring conversation on the future of healthcare, the power of scientific discovery, and the drive to improve patients' lives.

Check out the links to this episode here.